GP
ASML icon

Geneva Partners’s ASML ASML Stock Holding History

Geneva Partners’s Portfolio ASML Stock Details ASML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,285
Closed -$3.36M – 71
2024
Q2 		$3.36M Buy
3,285
+1,383
+73% +$1.33M 1.38% 29
2024
Q1 		$1.85M Buy
+1,902
New +$1.69M 0.81% 37
2023
Q3 		– Sell
-7,013
Closed -$5.08M – 66
2023
Q2 		$5.08M Buy
7,013
+1,877
+37% +$1.28M 3.32% 13
2023
Q1 		$3.5M Buy
+5,136
New +$3.3M 2.99% 13
2018
Q1 		– Sell
-5,230
Closed -$909K – 79
2017
Q4 		$909K Sell
5,230
-150
-3% -$26.5K 0.68% 54
2017
Q3 		$921K Buy
+5,380
New +$824K 0.73% 48

Other funds holding ASML

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geneva Partners's ASML Position: Q3 2024 in Review

Geneva Partners sold out of ASML (ASML) in Q3 2024, closing a stake of 3,285 shares — an estimated $3.36M sold.

Geneva Partners first reported a position in ASML in Q3 2017 and held it in 6 quarters. The position peaked at $5.08M in Q2 2023. 1,532 funds tracked by Wall St. Rank hold ASML as of Q3 2024.

  • Geneva Partners reported no remaining ASML position as of Q3 2024 after selling out during the quarter.
  • Geneva Partners sold 3,285 ASML shares in Q3 2024, an estimated $3.36M.
  • Geneva Partners first reported a position in ASML in Q3 2017 and held it in 6 quarters.
  • Geneva Partners's ASML position peaked at $5.08M in Q2 2023.
  • 1,532 funds tracked by Wall St. Rank held ASML as of Q3 2024.

Based on Geneva Partners's 13F filing for Q3 2024, filed 30 Oct 2024.